Cargando…

Bronchiectasis

The frequency of diagnosing bronchiectasis is increasing around the world. Cystic fibrosis is the most common inherited cause of bronchiectasis, but there is increasing recognition of significant numbers of patients with bronchiectasis from various causes. With increasing awareness of bronchiectasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Changhwan, Kim, Dong-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517943/
https://www.ncbi.nlm.nih.gov/pubmed/23236316
http://dx.doi.org/10.4046/trd.2012.73.5.249
_version_ 1782252494132346880
author Kim, Changhwan
Kim, Dong-Gyu
author_facet Kim, Changhwan
Kim, Dong-Gyu
author_sort Kim, Changhwan
collection PubMed
description The frequency of diagnosing bronchiectasis is increasing around the world. Cystic fibrosis is the most common inherited cause of bronchiectasis, but there is increasing recognition of significant numbers of patients with bronchiectasis from various causes. With increasing awareness of bronchiectasis, a significant number of research, concerning the causes and treatments, were published over the past few years. Investigation of the underlying cause of bronchiectasis is the most important key to effective management. The purpose of this report is to review the immunological abnormalities that cause bronchiectasis in those that the cystic fibrosis has been excluded, identify the available evidences of current management, and discuss several controversies in the treatment of this disorder.
format Online
Article
Text
id pubmed-3517943
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format MEDLINE/PubMed
spelling pubmed-35179432012-12-12 Bronchiectasis Kim, Changhwan Kim, Dong-Gyu Tuberc Respir Dis (Seoul) Review The frequency of diagnosing bronchiectasis is increasing around the world. Cystic fibrosis is the most common inherited cause of bronchiectasis, but there is increasing recognition of significant numbers of patients with bronchiectasis from various causes. With increasing awareness of bronchiectasis, a significant number of research, concerning the causes and treatments, were published over the past few years. Investigation of the underlying cause of bronchiectasis is the most important key to effective management. The purpose of this report is to review the immunological abnormalities that cause bronchiectasis in those that the cystic fibrosis has been excluded, identify the available evidences of current management, and discuss several controversies in the treatment of this disorder. The Korean Academy of Tuberculosis and Respiratory Diseases 2012-11 2012-11-30 /pmc/articles/PMC3517943/ /pubmed/23236316 http://dx.doi.org/10.4046/trd.2012.73.5.249 Text en Copyright©2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
spellingShingle Review
Kim, Changhwan
Kim, Dong-Gyu
Bronchiectasis
title Bronchiectasis
title_full Bronchiectasis
title_fullStr Bronchiectasis
title_full_unstemmed Bronchiectasis
title_short Bronchiectasis
title_sort bronchiectasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517943/
https://www.ncbi.nlm.nih.gov/pubmed/23236316
http://dx.doi.org/10.4046/trd.2012.73.5.249
work_keys_str_mv AT kimchanghwan bronchiectasis
AT kimdonggyu bronchiectasis